期刊文献+

介孔二氧化硅纳米粒介导的药物传递系统及其生物安全性的研究进展 被引量:8

Progress in Mesoporous Silica Nanoparticles-mediated Drug Delivery Systems and Their Biological Safety
原文传递
导出
摘要 介孔二氧化硅纳米粒(MSNs)是一种新型无机纳米材料,因具有独特的网状孔道结构、巨大的比表面积、孔径分布窄且可调节及易于表面修饰等特性,已用于药物控释系统的研究。MSNs载体的药物负载量与其介孔容积相关,表面经修饰后可实现药物的控释和靶向传递。然而,随着MSNs载体与人体接触的机会和时间日益增加,其安全性也受到广泛关注。本文综合近10年来国内外的相关文献,归纳了MSNs在递药系统中的应用,并分析了其生物安全性的影响因素。 Mesoporous silica nanoparticles (MSNs) are novel multifunctional inorganic nanosized materials,which have been extensively applied to develop the controlled-release drug delivery systems owing to their unique pore structures, large specific surface area, narrow and adjustable pore size distribution as well as ease of surface modification,The drug loading of MSNs is dependent on their mesopore volume. After surface modification, MSNs have the properties of controlled-release and targeted delivery. Meanwhile, the biological safety of MSNs comes in the spotlight with morechances and more time that the public expose trader them. This paper reviews the application of MSNs to drug delivery system through consulting related literatures at home and abroad in recent decade, the influence factors on their biologicalsafety are also systematically summarized.
机构地区 中南大学药学院
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2013年第1期81-87,共7页 Chinese Journal of Pharmaceuticals
关键词 介孔二氧化硅 载体 控释 靶向传递 生物安全性 综述 mesoporous silica carrier controlled-release targeted delivery biological safety review
  • 相关文献

参考文献29

  • 1Kresge CT,Leonowicz ME, Roth WJ, et al. Orderedmesoporous molecular sieves synthesized by a liquid-crystaltemplate mechanism [J]. Nature, 1992,359 (6397): 710-712.
  • 2Kanatzidis MG. Beyond silica: nonoxidic mesostructuredmaterials [J]. Adv Mat, 2007,19(9): 1165-1181.
  • 3He Q, Zhang Z,Gao Y,et al. Intracellular localizationand cytotoxicity of spherical mesoporous silica nano- andmicroparticles [J]. Small, 2009, 5 (23): 2722-2729.
  • 4Vallhov H, Gabrielsson S,Stramme M, et al. Mesoporoussilica particles induce size dependent effects on humandendritic cells [J]. Nano Lett, 2007, 7(12): 3576-3582.
  • 5Napierska D, Thomassen LC, Rabolli V, et al. Size-dependentcytotoxicity of monodisperse silica nanoparticles in humanendothelial cells [J]. Small, 2009, 5 (7): 846-853.
  • 6Zhang Y, Wang J, Bai X, et al. Mesoporous silicananoparticles for increasing the oral bioavailability andpermeation of poorly water soluble drugs [J]. Mol Pharm,2012,9(3):505-513.
  • 7Lai CY, Trewyn BG, Jeftinija DM, et al. A mesoporous silicananosphere-based carrier system with chemically removableCdS nanoparticle caps for stimuli-responsive controlledrelease of neurotransmitters and drug molecules [J]. J AmChem Soc, 2003,125(15): 4451-4459.
  • 8Park C, Oh K,Lee SC, et al. Controlled release of guestmolecules from mesoporous silica particles based on a pH-responsive polypseudorotaxane motif [J]. Angew Chem IntEd Engl 2001, 46(9): 1455-1457.
  • 9Angelos S,Khashab NM, Yang YW, et al, pH clock-operatedmechanized nanoparticles [J]. J Am Chem Soc, 2009,131 (36): 12912-12914.
  • 10Lin CH, Cheng SH, Liao WN, et al, Mesoporous silicananoparticles for the improved anticancer efficacy of cis-platin [J]. Int J Pharm, 2012, 429 (1-2): 138-147.

二级参考文献1

共引文献99

同被引文献141

引证文献8

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部